The NordICC Study: Rationale and design of a randomized trial on colonoscopy screening for colorectal cancer

Endoscopy

Volumn 44, Issue 7, 2012, Pages 695-702

  Kaminski, M F ^c   Bretthauer, M ^a,b   Zauber, A G ^d   Kuipers, E J ^e   Adami, H O ^f,g   Van Ballegooijen, M ^e   Regula, J ^c   Van Leerdam, M ^e   Stefansson, T ^h   Pahlman, L ⁱ   Dekker, E ^j   Hernan M A ^f   Garborg, K ^k   Hoff, G ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g KAROLINSKA INSTITUTE   (Sweden)

^h LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

ⁱ UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^j Medical Centre ^*  (Netherlands)

^k Sørlandet Hospital   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CLINICAL EFFECTIVENESS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; MULTICENTER STUDY; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STUDY DESIGN; CLINICAL TRIAL; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; EARLY DIAGNOSIS; EUROPE; FEMALE; INCIDENCE; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MORTALITY; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; REGISTER; STATISTICS; SURVIVAL; TREATMENT OUTCOME;

COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SELECTION; REGISTRIES; RESEARCH DESIGN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84862556719     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0032-1306895     Document Type: Article

References (57)

1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 765-781
2. Pox C, SchmiegelW, ClassenM. Current status of screening colonoscopy in Europe and in the United States. Endoscopy 2007; 39: 168-173 (Pubitemid 46394831)
3. Butruk E, Regula J, Polkowski M et al. National colorectal cancer screening programme in Poland. Endoscopy 2002; 34: 939-940 (Pubitemid 35331193)
4. Rex DK, Johnson DA, Anderson JC et al. American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008. Am J Gastroenterol 2009; 104: 739-750
5. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365-1371 . (Pubitemid 23131388)
6. [Erratum, N Engl J Med 1993; 329: 672.]
7. Kronborg O, Fenger C, Olsen J et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-1471 (Pubitemid 26400241)
8. Hardcastle JD, Chamberlain JO, Robinson MHE et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477 (Pubitemid 26400242)
9. Winawer SJ, Zauber AG, Ho MN. The National Polyp Study Workgroup. et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329: 1977-1981 (Pubitemid 24015040)
10. Atkin WS, Cuzik J, Northover JMA et al. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993; 341: 736-740 (Pubitemid 23085190)
11. Thiis-Evensen E, Hoff G, Sauar J et al. Population-based surveillance by colonoscopy: Effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999; 34: 414-420 (Pubitemid 29232378)
12. Selby JV, Friedman GD, Quesenberry CP Jr et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326: 653-657
13. Atkin WS, Edwards R, Kralj-Hans I et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicenter randomized trial. Lancet 2010; 375: 1624-1633
14. Rex DK, Rahmani EY, Haseman JH et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997; 112: 17-23 (Pubitemid 27008980)
15. Pickhardt PJ, Nugent PA, Mysliwiec PA et al. Location of adenomas missed by optical colonoscopy. Ann Intern Med 2004; 141: 352-359
16. Kaminski MF, Regula J, Kraszewska E et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010; 362: 1795-1803
17. McCallion K, Mitchell RM, Wilson RH et al. Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening. Gut 2001; 48: 522-525 (Pubitemid 32234797)
18. Rabeneck L, Davila JA, El-Serag HB. Is there a true "shift" to the right colon in the incidence of colorectal cancer? Am J Gastroenterol 2003; 98: 1400-1409
19. Schoenfeld P, Cash B, Flood A et al. Colonoscopic screening of averagerisk women for colorectal neoplasia. N Engl J Med 2005; 352: 2061-2068 (Pubitemid 40664307)
20. Morikawa T, Kato J, Yamaji Y et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005; 129: 422-428 (Pubitemid 41096630)
21. Guittet L, Bouvier V, Mariotte N et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007; 56: 210-214
22. Hol L, Van Leerdam ME, Van Ballegooijen M et al. Screening for colorectal cancer; randomized trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2009; 59: 62-68
23. Levin B, Lieberman D, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the USMulti-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-1595 (Pubitemid 351615355)
24. Regula J, RupinskiM, Kraszewska E et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006; 355: 1863-1872 (Pubitemid 44664644)
25. Mandel JS, Church TR, Bond JH et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-1607 (Pubitemid 32162983)
26. Winawer SJ, Zauber AG, Ho MN. The National Polyp Study Workgroup. et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329: 1977-1981 (Pubitemid 24015040)
27. Zauber AG, Winawer SJ, O'Brien MJ et al. Significant long term reduction in colorectal cancer mortality with colonoscopic polypectomy: findings of the National Polyp Study. Gastrointest Endosc 2007; 65: AB268
28. Citarda F, Tomaselli G, Capocaccia R. The Italian Multicenter Study Group. et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001; 48: 812-815 (Pubitemid 32476984)
29. Baxter NN, Goldwasser MA, Paszat LF et al. Association of colonoscopy and death from colorectal cancer: A population-based, case-control study. Ann Intern Med 2008; 150: 1-8
30. Brenner H, Chang-Claude J, Seiler CM et al. Protection from colorectal cancer after colonoscopy: A population-based study, case-control study. Ann Intern Med 2011; 154: 22-30
31. Inadomi J, Kuhn L, Vijan S et al. Adherence to competing colorectal cancer screening strategies. Am J Gastroenterol 2005; 100: S387-S388
32. Hoff G, Grotmol T, Skovlund E et al. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomized controlled trial. BMJ 2009: DOI: 10.1136/bmj.b1846
33. Atkin WS, Hart A, Edwards R et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 1998; 42: 560-565 (Pubitemid 28186576)
34. Segnan N, Senore C, Andreoni B et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 2007; 132: 2304-2312 (Pubitemid 46900821)
35. Kahi CJ, Imperiale TF, Juliar BE et al. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 2009; 7: 770-775
36. Rabeneck L, Paszat LF, Hilsden RJ et al. Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology 2008; 135: 1899-1906
37. Levin TR, Zhao W, Conell C et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med 2006; 145: 880-886 (Pubitemid 351639963)
38. Stemmermann GN. Cancer of the colon and rectum discovered at autopsy in Hawaiian Japanese. Cancer 1966; 11: 1567-1572
39. Larsen IK, Grotmol T, Almendingen K et al. Impact of colorectal cancer screening on future lifestyle choices: A three-year randomized controlled trial. Clin Gastroenterol Hepatol 2007; 5: 477-483 (Pubitemid 46584834)
40. Ahlquist DA. Fecal occult blood testing for colorectal cancer. Can we afford to do this? Gastroenterol Clin North Am 1997; 26: 41-55
41. Moayyedi P, Achkar E. Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data Am J Gastroenterol 2006; 101: 380-384
42. Segnan N, Patnick J, von Karsa L eds. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: European Union; 2010: ISBN 978-92-79-16574-0 DOI: 10.2772/15379
43. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chron Dis 1967; 20: 637-648
44. McMahon AD. Study control, violators, inclusion criteria and defining explanatory and pragmatic trials. Stat Med 2002; 21: 1365-1376 (Pubitemid 34495605)
45. Harewood GC, Wiersema MJ, Melton LJ 3rd . A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 2002; 97: 3186-3194 (Pubitemid 35428814)
46. Hoff G, Bretthauer M. Appointments timed in proximity to annual milestones and compliance with screening: randomized controlled trial. BMJ 2008; 337: a2794 DOI: 10.1136/bmj.a2794
47. Bretthauer M, Lynge AB, Thiis-Evensen E et al. Carbon dioxide insufflation in colonoscopy: safe and effective in sedated patients. Endoscopy 2005; 37: 706-709 (Pubitemid 41078901)
48. Hamilton SR, Aaltonen LA eds.World Health Organization classification of tumours. Pathology and genetics of tumors of the digestive system. Lyon: IARC Press; 2000: 104-119
49. Hoff G, Ottestad PM, Skafløtten SR et al. Quality assurance as an integrated part of the electronic medical record -a prototype applied for colonoscopy. Scand J Gastroenterol 2009; 4: 1-7
50. Naslund U, Grip L, Fischer-Hansen J et al. The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial. Eur Heart J 1999; 20: 771-777
51. ICD-10 International statistical classification of diseases and related health problems. 10th revision. 2. Geneva:World Health Organization; 2004
52. Lisi D, Hassan C, CrespiM. AMOD Study Group. Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study. Dig Liver Dis 2009; 42: 371-376
53. Cuzick J, Edwards R, Segnan N. Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med 1997; 16: 1017-1029 (Pubitemid 27198989)
54. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549-556 (Pubitemid 10242750)
55. Robertson DJ, Greenberg ER, Beach M et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005; 129: 34-41 (Pubitemid 41002040)
56. Jorgensen OD, Kronborg O, Fenger C. The Funen Adenoma Follow-up Study. Incidence and death from colorectal carcinoma in an adenoma surveillance program. Scand J Gastroenterol 1993; 28: 869-874 (Pubitemid 23294759)
57. Hoff G, Bretthauer M, Huppertz-Haus G et al. The Norwegian Gastronet project: Continuous quality improvement of colonoscopy in 14 Norwegian centres. Scand J Gastroenterol 2006; 41: 481-487 (Pubitemid 43675416)